Bosh sahifaGXEA • FRA
add
Galapagos NV - ADR
Yopilish kursi
24,60 €
Kunlik diapazon
24,60 € - 24,60 €
Yillik diapazon
20,00 € - 37,00 €
Bozor kapitalizatsiyasi
1,66 mlrd EUR
Oʻrtacha hajm
30,00
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 62,43 mln | 6,59% |
Joriy xarajat | 21,40 mln | 5,88% |
Sof foyda | 90,22 mln | 288,76% |
Sof foyda marjasi | 144,51 | 264,74% |
Har bir ulushga tushum | 0,36 | 2,86% |
EBITDA | -27,30 mln | -172,39% |
Amaldagi soliq stavkasi | -2,48% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,56 mlrd | -10,83% |
Jami aktivlari | 4,36 mlrd | -5,85% |
Jami passivlari | 1,47 mlrd | -29,08% |
Umumiy kapital | 2,90 mlrd | — |
Tarqatilgan aksiyalar | 65,90 mln | — |
Narxi/balansdagi bahosi | 0,56 | — |
Aktivlardan daromad | -1,90% | — |
Kapitaldan daromad | -2,90% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | mar, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 90,22 mln | 288,76% |
Operatsiyalardan naqd pul | -122,43 mln | -29,06% |
Sarmoyadan naqd pul | 29,66 mln | 110,28% |
Moliyadan naqd pul | -1,17 mln | -514,74% |
Naqd pulning sof oʻzgarishi | -93,44 mln | 75,67% |
Boʻsh pul | -124,07 mln | -261,23% |
Haqida
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Tashkil etilgan
1999
Sayt
Xodimlar soni
1 123
